Opendata, web and dolomites

Gasgon SIGNED

Development of a Novel Medical Device to Remove Air Bubbles from Medicines, Which Will Improve Patient Safety and Reduce Costs of IV Infusion

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Gasgon project word cloud

Explore the words cloud of the Gasgon project. It provides you a very rough idea of what is the project "Gasgon" about.

disruptive    patent    medicine    brain    man    first    globally    gas    complications    wasted    vent    complication    infusions    extreme    providers    medical    blocking    adverse    mechanical    blood    solutions    enter    innovation    clinicians    filters    unmet    block    reliably    financial    regardless    heart    patients    labour    over    bubbles    patient    outcomes    fluid    embolism    acts    carry    form    automatic    remove    risk    billion    prescribed    unsuitable    inpatients    intervene    attack    dose    reduce    positively    line    strain    human    infusion    flow    gasgon    alarms    fluids    hours    optimise    pending    health    invented    bubble    position    air    intensive    environment    healthcare    puts    clinical    80    disposable    market    burden    opportunity    entering    medications    break    venous    electronic    220mn    removing    place    reducing    dysfunction    serious    performance    treatments    stroke    interrupting    deadly    intravenous    majority    treatment    global    sepsis    potentially    death    efficacy    receiving   

Project "Gasgon" data sheet

The following table provides information about the project.

Coordinator
TESSEN SOLUTIONS LIMITED 

Organization address
address: RUBICON CENTRE, BISHOPSTOWN. CO. CORK, IRELAND
city: Cork
postcode: n.a.
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Ireland [IE]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2020
 Duration (year-month-day) from 2020-01-01   to  2020-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TESSEN SOLUTIONS LIMITED IE (Cork) coordinator 50˙000.00

Map

 Project objective

Over 2 billion medical intravenous (IV) infusions occur each year globally, with over 80% of inpatients receiving IV treatment. Each of these infusions carry a serious health risk – the risk that gas bubbles enter with the fluid and block blood flow in patients. Air Embolism, a potentially deadly complication of IV infusion, is a result of bubbles entering the venous system and blocking blood flow leading to serious adverse complications for patients such as Sepsis, Stroke, Brain Dysfunction and Heart Attack. In extreme cases death can occur. Gasgon Medical has built a break-through and disruptive technology to reduce risk and optimise fluid management in common medical IV treatments. Currently clinicians must intervene to remove every bubble in every infusion, a labour-intensive practice that puts a strain on healthcare resources, with wasted man-hours and reduced efficacy of the medicine dose. Technology solutions on the market include electronic alarms and in-line filters – these are unsuitable in the majority of cases and place a significant human and financial burden on healthcare providers. Our innovation, which is a new form of ‘vent’ technology, will solve this unmet clinical need. Gasgon Medical has invented the first mechanical, in-line, automatic vent capable of removing bubbles from IV fluids regardless of position or environment. Our Patent-pending disposable vent acts quickly and reliably without interrupting or reducing the prescribed dose of medications. This represents a major technology advancement over current methods of managing risk in IV infusions. Gasgon Medical can lead a €220mn IV vent opportunity bringing an exciting European innovation to the global market. This novel Gasgon vent technology has the potential to positively impact healthcare delivery and performance, leading to better patient outcomes.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GASGON" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GASGON" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

ECOBIOMASS (2019)

Achieving unique wines through an efficient production process

Read More  

PREDICT (2019)

Big Data EEG-Analysis for Advanced Personalised Medicine in Depression

Read More  

Dyme (2019)

Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any cont

Read More